lobbying_activities: 2307857

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2307857	c0cce518-5866-4f11-94e9-a014d0b75f05	Q2	PRIME THERAPEUTICS	400339576	PRIME THERAPEUTICS	2019	second_quarter	PHA	Request for Information: HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs, provisions affecting market competition for prescription drugs and the drug supply chain.	HOUSE OF REPRESENTATIVES,SENATE		83000	0	0	2019-07-17T15:07:03.857000-04:00